Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
No. of Analysts
1Y Price Target
Q3 EPS Estimate
Q3 Revenue Estimate
Price, EPS and Revenue Projections
Strong Buy
3
Buy
3
Hold
1
Sell
0
Strong Sell
0
updated on
Dec 03, 2025
Bearish
3
Neutral
5
Bullish
6
Bearish
34
Neutral
5
Bullish
7
Bearish
31
Neutral
0
Bullish
1
Sanofi Consumer Healthcare India Limited focuses on the consumer healthcare segment after being demerged from Sanofi India Limited.
The demerger was implemented as part of a Scheme of Arrangement, effective from June 1, 2024, marking a new phase for the company.
23,030,622 equity shares were issued to shareholders of Sanofi India Limited as part of the demerger process.
The company's focus will likely involve leveraging its strong brand association with Sanofi to penetrate the consumer healthcare market effectively.
Pharmaceuticals
Pharmaceuticals - Multinational
10,559 Cr
Low Risk
49.1
41.4
1.6
41.1
5,954.00
4,360.30
Sales CAGR
1Y
30.45%
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
9.76%
3Y
—
5Y
—
10Y
—
ROE
TTM
77.82%
3Y
—
5Y
—
10Y
—
ROCE
TTM
92.58%
3Y
—
5Y
—
10Y
—
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Get In-depth insights on EPS and Revenue forecasts
Performance
UNDER PERFORMER
Valuation
OVERVALUED
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
LOW RISK
Market Cap
₹ 10,559 Cr
P/E
49.14
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
27823.45 | 59,278 Cr | 39.28 | 14.78 | 1.70 | 37.62 | 48.38 | 26.50 | |
2592.50 | 43,623 Cr | 45.76 | 25.54 | 2.10 | 55.94 | 74.64 | 26.06 | |
5018.10 | 22,933 Cr | 32.45 | 5.96 | 3.29 | 18.36 | 24.12 | 18.22 | |
9026.00 | 22,811 Cr | 98.68 | 28.55 | 0.35 | 28.93 | 37.48 | 12.33 | |
4567.30 | 10,559 Cr | 49.14 | 41.08 | 1.20 | 77.82 | 92.58 | 51.64 | |
4172.05 | 9,666 Cr | 25.45 | 11.23 | 2.78 | 42.11 | 52.41 | 25.64 | |
5703.25 | 9,422 Cr | 30.71 | 15.20 | 2.20 | 49.51 | 65.17 | 34.30 |
